Related content

Delayed first injection of the once-a-month injectable contraceptive containing 25 mg of medroxyprogesterone acetate and 5 mg of E 2 -cypionate: effects on ovarian function

By Petta C.A.   Hays M.   Brache V.   Massai R.   Hua Y.   Alvarez-Sanchez F.   Croxatto H.   d'Arcangues C.   Cook L.A.   Bahamondes L.  

Fertility and Sterility, Vol. 75, Iss. 4, 2001-04 ,pp. : 744-748

Elsevier

Access to resources Recommend Favorite

Painless Depo-medroxyprogesterone acetate (DMPA) injections using the 'pinch technique'

By Fletcher H  

Journal of Obstetrics & Gynaecology, Vol. 24, Iss. 5, 2004-08 ,pp. : 562-563

Informa Healthcare

Access to resources Recommend Favorite

A randomized,open-label study of conjugated equine estrogens plus medroxyprogesterone acetate versus tibolone: effects on symptom control, bleeding pattern, lipid profile and tolerability

By Baracat E. C.   Barbosa I. C.   Giordano M. G.   Haidar M. A.   Marinho R. M.   Menegocci J. C.   Morais K. M.   Tomaz G.   Wehba S.  

Climacteric, Vol. 5, Iss. 1, 2002-03 ,pp. : 60-69

Informa Healthcare

Access to resources Recommend Favorite

Plasma leptin in postmenopausal women with coronary artery disease: effect of transdermal 17β-estradiol and intermittent medroxyprogesterone acetate

By Os I.   Os A.   Abdelnoor M.   Larsen A.   Birkeland K.   Westheim A.  

Climacteric, Vol. 6, Iss. 3, 2003-09 ,pp. : 204-210

Informa Healthcare

Access to resources Recommend Favorite

Sequential addition of low dose of medrogestone or medroxyprogesterone acetate to transdermal estradiol: a pilot study on their influence on the endometrium

By Pansini F.   Paoli D.D.   Albertazzi P.   Bonaccorsi G.   Campobasso C.   Zanotti L.   Pisati R.   Giulini N.A.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 68, Iss. 1, 1996-09 ,pp. : 137-141

Elsevier

Access to resources Recommend Favorite